🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Initial results of a multicenter phase II trial of intravesical gemcitabine + BCG for patients with BCG-exposed non-muscle invasive #BladderCancer. Presentation by Gal Wald Weill Cornell Medicine Urology. #SUO24 written coverage by Rashid K. Sayyid USC on UroToday > bit.ly/4gmrkD9 Society of Urologic Oncology

Gal Wald, MD, shares the rationale for a trial of BCG plus gemcitabine in high-grade NMIBC. #SUO24 Gal Wald Weill Cornell Medicine Urology urologytimes.com/view/gal-wald-…

Video in @UroToday: Sam S. Chang MD, MBA chats with @waldogmed and Eugene Pietzak about intravesical gemcitabine and BCG combination therapy for BCG-exposed non-muscle-invasive bladder cancer. Click to watch the video: urotoday.com/video-lectures…

ASCO #GU25 Poster Session #BladderCancer UrologyMSK Muneeb Alam Eugene Pietzak E6- The impact of micropapillary histology and clinical staging on OS ✨130 pts ✨Presence of micropappillary predicts poor prognosis, regardless of its proportion ‼️ 👉The key predictor of

Fun to get together with the talented and dedicated NewYork-Presbyterian Weill Cornell Medicine Urology residents!

Phase II trial explores gemcitabine + BCG for BCG-exposed #BladderCancer. Eugene Pietzak Memorial Sloan Kettering Cancer Center & Gal Wald Weill Cornell Medicine Urology join Sam S. Chang MD, MBA Vanderbilt Urology to discuss this phase II trial that demonstrates promising results with a 94% complete response rate at six months

Comparative outcomes of intralesional #collagenase injection for #PeyroniesDisease: acute vs. stable phase treatment👉nature.com/articles/s4144… Manish Kuchakulla NewYork-Presbyterian Weill Cornell Medicine Hriday Bhambhvani, MD Weill Cornell Medicine Urology Gal Wald

We are so excited for #AUA25 to begin in few weeks! Our faculty, fellows and residents are looking forward to participating in a variety of sessions as well as connecting with colleagues. Scroll⏬ to learn more about what our trainees will be presenting during the meeting.

Congratulations to Aaron Gurayah, MD (Aaron Gurayah, MD), PGY2 resident, for winning best poster for his research on barriers to prostate cancer screening under the mentorship of Dr. Meena Davuluri (Meena Davuluri, MD, MPH) at #AUA25! We are so proud of you!

Recovery of urinary continence after robotic-assisted radical prostatectomy: A multicenter comparison of Retzius-sparing, hood, and standard techniques. Presented by Gal Wald Weill Cornell Medicine Urology. #AUA25 written coverage by Zach Klaassen Georgia Cancer Center on UroToday >

Studies and clinical trials related to decision-making insights and market demand for early infant male circumcision with ShangRing in Kenya, Tanzania, and Uganda received great attention at the 2025 AUA. Lina Posada and @ Gal Wald did an excellent job showcasing our work

Highlights from #SUO24! Amy Luckenbaugh Vanderbilt Health & Sam S. Chang MD, MBA Vanderbilt Urology dive into late-breaking #bladdercancer trials—combo intravesical gem/BCG for BCG-exposed & phase III cretostimogene in BCG-unresponsive CIS. Key takeaway? More options than ever for #NMIBC, with

Jim C. Hu, MD, (Jim Hu) details findings from a study comparing urinary continence recovery across standard, Retzius-sparing, and Hood RARP techniques. #AUA25 Weill Cornell Medicine Urology urologytimes.com/view/jim-hu-md…

Humbled and honored to be among this year’s Conquer Cancer, the ASCO Foundation YIA grant recipients. Indebted to my mentors — Dr. Eugene Pietzak , Dr. Gopa Iyer , and the team at UrologyMSK Memorial Sloan Kettering Cancer Center — for their unwavering guidance and support. Excited for the future #ASCO25

Thank you for the wonderful year Jim Hu Incredible way to round it out and begin PGY5

Congratulations to our current chief residents, Drs. Lina Posada Calderon & Oakley Strasser on their urologic oncology fellowship matches! We are so proud of all you have accomplished throughout your residency, and we wish you luck as you both begin your fellowships next year!

👀 ⭐️Gal Wald NewYork-Presbyterian Keith Kowalczyk, MD Georgetown University Urology 10th European Urology journals Surgery in Motion. Largest comparison of Hood, Retzius vs Std Robotic RP: Retzius>Hood>Std continence recovery, but ⬆️ Retzius + SMs sciencedirect.com/science/articl…

Pelvic fascia‑sparing during RARP improves urinary continence recovery 🧬 Posterior PFS: 90% Blair mo, 96% $ mo, 97% 20 mo 🧠 Anterior PFS: 83% Blair mo, 89% $ mo, 99% 20 mo 🔬 Both techniques ~3.5‑fold ↑ continence at 3 mo; only posterior PFS sustained benefit at 20 mo